All In Biotech

Free tool

FAERS Monitor: Humulin N

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 018781 or its brand name (Humulin N, Insulin Susp Isophane Recombinant Human). Reports on generic versions are filed under their own applications.

Reports

21,096

Serious

13,620

65% of reports

Hospitalization

7,304

Death reported

1,540

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased4,946
  • blood glucose decreased1,737
  • drug ineffective1,558
  • hypoglycaemia927
  • incorrect dose administered881
  • maternal exposure during pregnancy784
  • nausea766
  • fall759
  • weight decreased738
  • dyspnoea722
  • visual impairment698
  • diarrhoea663
  • malaise611
  • dizziness595
  • headache581

Reports by year received

View as table
YearReports
2004764
2005778
2006832
2007509
2008458
2009535
2010554
2011456
2012494
2013542
2014939
20154,149
20161,096
2017897
20181,033
2019967
2020943
2021919
20221,048
2023944
2024911
2025825
2026503

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,063 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood glucose decreasedSignal1,73737.435.759,377
blood glucose increasedSignal4,94626.926.2120,926
hypoglycaemiaSignal92719.418.215,893
maternal exposure during pregnancySignal7848.88.25,418
visual impairmentSignal6985.65.22,662
incorrect dose administeredSignal8813.93.61,876
weight decreasedSignal7382.62.5758
fallSignal7592.32.1550
malaise6111.41.368
dyspnoea7221.31.243
dizziness5951.21.118
drug ineffective1,5581.21.145
diarrhoea6631.01.00
nausea7661.00.91
headache5810.90.94

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.